MegatrendsMegatrends: not the usual suspects, but who actually profits.View megatrends →

Chemed Stock

Chemed Corporation

CHENYSEMarkt
US$512.38
-0.6% today

Company data

Sector
Healthcare
Industry
Medical - Care Facilities
Country
United States
CEO
Kevin J. McNamara
Employees
15,811
Market cap
$6.7 B
IPO
03/05/1973

Chemed Corporation is a healthcare company headquartered in Cincinnati, Ohio. The company was incorporated in 1970 and is led by CEO Kevin J. McNamara. The business operates through two primary segments, which are the VITAS segment and the Roto-Rooter segment. Within its medical services operations, the company…

Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.

Chemed stock: price history

16/10/25+18.9 %16/10/26

1D

-0.6%

1W

+2.5%

1M

+0.5%

6M

+33.2%

YTD

+19.8%

1Y

+18.9%

2Y

-15.6%

5Y

+19.1%

10Y

+266.5%

Next earnings date

Next earnings date

27/10/2026 (in 10 days)

Volatility around earnings

~77% stronger price swings than usual

Chemed stock scores

  • Valuation

    Visible after free registration

  • Trend

    Visible after free registration

  • Quality

    Visible after free registration

  • Dividend

    Visible after free registration

  • Growth

    Visible after free registration

  • Insider

    Visible after free registration

  • Earnings

    Visible after free registration

  • Revisions

    Visible after free registration

  • Sentiment

    Visible after free registration

  • Short Pressure

    Visible after free registration

Register for free

Unlock all 11 scores

  • 5 credits free on registration
  • Access to virtual portfolios and watchlist
  • No credit card, no payment details needed
  • No subscription, no minimum term
  • Our own servers in Germany, no US cloud
Create account →

Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.

Business model & megatrends

Business model

Robust business model that benefits noticeably from at least one megatrend.

Why this value? Details with Pro only.

1 more assignment (Enabler/Second row) Pro-only.

Chemed Corporation operates in two distinct business segments. Through the VITAS segment, the company provides specialized hospice and palliative care services for patients, encompassing medical care as well as spiritual and emotional support. The second segment, Roto-Rooter, offers comprehensive cleaning and facility maintenance services such as pipe cleaning, excavation, and water recovery. These services are provided to both private and commercial customers through company-owned locations or franchise models. The business model thus combines specialized medical services with a broad-based skilled trades service offering.

Revenue model
Mixed
Recurring revenue
Medium
Pricing power
Weak
Moat
Narrow
Moat type
Switching costs
Capital intensity
High
Customer concentration
Unknown

Ask the agents about Chemed

Analyst assessment of Chemed

PRICE TARGET LOW

US$650.00

CONSENSUS

US$650.00

MEDIAN

US$650.00

PRICE TARGET HIGH

US$650.00

0

STRONG BUY

3

BUY

6

HOLD

0

SELL

0

STRONG SELL

9

TOTAL · Hold

As of: 31/07/2026

ANALYST FIRMRATINGACTIONDATE
OppenheimerOutperformmaintain31/07/2026
RBC CapitalSector Performmaintain30/07/2026
B of A SecuritiesNeutralmaintain09/07/2026
RBC CapitalSector Performmaintain27/04/2026
OppenheimerOutperformmaintain27/02/2026
RBC CapitalOutperform → Sector Performdowngrade27/02/2026
JefferiesBuy → Holddowngrade22/01/2026
RBC CapitalOutperformmaintain10/11/2025

Chemed stock metrics

P/E

25.72

P/B

8.28

EV/EBITDA

16.18

RETURN ON EQUITY

8.2%

NET MARGIN

10.1%

DEBT/EQUITY

0.4

DIVIDEND YIELD

0.5%

AS OF

30/06/2026

Free float & liquidity

FREE FLOAT

98.1%

FLOAT SHARES

12,822,977

AVG. DAILY VOLUME (30D)

147,556

Insider transactions (SEC)

ROLETRANSACTIONSHARESPRICEPLAN TYPEDATE

LEE SPENCER S

OfficerTax settlement11,160508.93Spontaneous01/10/2026

LEE SPENCER S

OfficerOption exercise12,099445.35Spontaneous01/10/2026

MCNAMARA KEVIN J

OfficerSale2,000513.45Spontaneous30/09/2026

HUTTON THOMAS C

OfficerOption exercise4,629445.35Spontaneous29/09/2026

HUTTON THOMAS C

OfficerTax settlement4,270506.65Spontaneous29/09/2026
Page 1 / 6

Attention

1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.6%

Forums (Reddit)

09/0910/0911/09

Institutional holders

FUND / INSTITUTIONSHARESCHANGEAS OF
Copeland Capital Management, LLC146,833+1,82630/09/2026
FENIMORE ASSET MANAGEMENT INC36,631+10330/09/2026
Signal Advisors Wealth, LLC17,713-2,85230/09/2026
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC10,474-1,02530/09/2026
Strong Retirement Solutions LLC7,635-65830/09/2026
Page 1 / 3

Dividends & Stock splits

Dividends

EX-DATEPAY DATEAMOUNTYIELD
17/08/202603/09/2026US$0.700.5 %
28/05/202616/06/2026US$0.600.5 %
23/02/202613/03/2026US$0.600.5 %
17/11/202505/12/2025US$0.600.5 %
11/08/202529/08/2025US$0.600.5 %
Page 1 / 8

Stock splits

DATERATIO
12/05/20052:1
12/11/19812:1

Comparable stocks

Frequently asked questions about Chemed stock

What does Chemed do?

Chemed Corporation is a company in the Healthcare sector, Medical - Care Facilities industry, headquartered in United States.

The CEO is Kevin J. McNamara, the company employs around 15,811 people.

The IPO was on 03/05/1973; the stock trades on NYSE under the ticker CHE.

What do analysts say about Chemed stock?

9 analysts rate the stock, the consensus is Hold (as of 31/07/2026).

The average price target is US$650.00, ranging from US$650.00 to US$650.00, with a median of US$650.00.

This is an external assessment, not a statement by Market Jury.

When does Chemed report next?

The next earnings date is 27/10/2026.

Around past earnings, price swings were roughly 77% stronger than usual.

Does Chemed pay a dividend?

Yes. The last dividend was US$0.70 per share, ex-date 17/08/2026, paid on 03/09/2026.

The dividend yield is 0.5% (as of 30/06/2026).

Which stocks are comparable to Chemed?

Comparable stocks include HCA Healthcare, Tenet Healthcare, DaVita, Universal Health Services, Hims & Hers Health, LifeStance Health Group, Concentra Group Holdings Parent and Acadia Healthcare Company.

How can I get Chemed stock analyzed?

Clicking "Analyze stock" lets five strategies assess Chemed against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.

Not investment advice. Past performance is not an indicator of future results.